To study effect of Vitamin D supplementation in asthma patients
Not Applicable
- Conditions
- Health Condition 1: J00-J99- Diseases of the respiratory system
- Registration Number
- CTRI/2021/09/036165
- Lead Sponsor
- Dr Preeti Navik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age Group more then 18 years
Patients of mild and moderate asthma taking Budesonide plus Formoterol treatment
Exclusion Criteria
Patients already taking vitamin D supplements
Inability to perform adequate spirometry
Patients of Asthma COPD overlap syndrome ACOS
Patients with renal stones
Patients taking liquid paraffin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the response of changes in spirometry FEV1 Forced expiratory volume per second ,FEV/FVC , PEFR Peak expiratory flow rateTimepoint: To compare the response of changes in spirometry FEV1 Forced expiratory volume per second ,FEV/FVC , PEFR Peak expiratory flow rate at baseline, at the end of 4 weeks, at the end of 8 weeks
- Secondary Outcome Measures
Name Time Method To compare the frequency of episodes of asthma <br/ ><br>To compare the asthma related quality of life score <br/ ><br>Timepoint: study will be conducted from july 2021 to oct 2022